Browse by Theme: Sexual Reproductive & Maternal Health

In 2012, CARE joined other civil society organisations, governments and donors to commit to providing an additional 120 million women and girls with family planning information and services by 2020. This report reviews CARE's progress towards our 2020 Family Planning commitments.

Read more...

FP2020 has brought a powerful focus on family planning – but we must accelerate progress and fill key gaps to ensure we reach all people with the contraception/family planning services they want and need.

Read more...

Of the 225 million women with unmet need for family planning, many live in areas affected by conflict or natural disasters. Delivering family planning services in these settings is critical to ensuring countries meet their FP2020 goals, as well as to fulfilling the sexual and reproductive health rights of the more than 32 million women and girls in need of humanitarian aid.

Read more...

This research brief provides an overview of the impact of project interventions and CARE’s best practices under the GSK ‘20% Reinvestment Initiative’ in Asia. This strategic partnership between CARE and GSK focuses on improving maternal and neonatal child health by improving the quantity and quality of frontline community health workers in the most remote and marginalised communities in Afghanistan, Bangladesh, Cambodia, Laos, Myanmar and Nepal.

Read more...

This research brief is part of a series capturing the impact of project interventions and analysing and documenting CARE’s best practices under the GSK ‘20% Reinvestment Initiative’ in Asia. This briefing focuses on the case of Nepal.

Read more...

This research brief is part of a series capturing the impact of project interventions and analysing and documenting CARE’s best practices under the GSK ‘20% Reinvestment Initiative’ in Asia. This briefing focuses on the case of Bangladesh.

Read more...

This research brief is part of a series capturing the impact of project interventions and analysing and documenting CARE’s best practices under the GSK ‘20% Reinvestment Initiative’ in Asia. This briefing focuses on the case of Afghanistan.

Read more...
Page 1 of 4